GlaxoSmithKline Consumer Healthcare Limited

Equities

500676

INE264A01014

GlaxoSmithkline Consumer Healthcare Ltd Announces Board Changes, Effect from September 01, 2016

August 06, 2016 at 03:11 pm

GlaxoSmithkline Consumer Healthcare Ltd. announced that the board meeting held on August 05, 2016, Mr. Anup Dhingra has been appointed as an Executive Director of the company, with effect from September 01, 2016, in the casual vacancy created by the resignation of Mr. Jaiboy John Phillips, who will hold office till August 31, 2016.

Latest news about GlaxoSmithKline Consumer Healthcare Limited

GlaxoSmithKline Consumer Healthcare : Launches Saline Nasal Wash Product	18/12/20	MT
Market Chatter: GSK Consumer Plans Local Manufacturing of Polident Brand in India	01/12/20	MT
GlaxoSmithKline Consumer Healthcare : GSK Consumer Healthcare Launches Denture Care Brand in India	26/11/20	MT
InveniAI Corporation Enters Strategic Artificial Intelligence and Machine Learning Focused Collaboration with GlaxoSmithKline Consumer Healthcare	29/07/20	CI
GlaxoSmithKline Consumer Healthcare Limited(BSE:500676) dropped from S&P Global BMI Index	16/04/20	CI
GlaxoSmithKline Consumer Healthcare Limited(NSEI:GSKCONS) dropped from FTSE All-World Index	16/04/20	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q3 2020 Earnings Call, Feb 07, 2020	07/02/20
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	06/02/20	CI
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	08/11/19	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q2 2020 Earnings Call, Nov 08, 2019	08/11/19
GlaxoSmithKline Consumer Healthcare Limited Announces Resignation of Vivek Anand from the Board	27/09/19	CI
GlaxoSmithKline Consumer Healthcare Limited Announces Cessation of Directors	09/08/19	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q1 2020 Earnings Call, Aug 05, 2019	05/08/19
GlaxoSmithKline Consumer Healthcare Limited Declares Dividend for the Year Ended March 31, 2019	03/08/19	CI
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	01/08/19	CI
Glaxosmithkline Consumer Healthcare Limited Recommends Total Dividend for the Year Ended March 31, 2019, Payable on September 2, 2019	27/06/19	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q4 2019 Earnings Call, May 13, 2019	13/05/19
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	10/05/19	CI
GlaxoSmithKline Consumer Healthcare Limited Recommends Dividend, Payable on or Before September 1, 2019	10/05/19	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q3 2019 Earnings Call, Feb 15, 2019	15/02/19
Glaxosmithkline Consumer Healthcare Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018	14/02/19	CI
GSK Says Considering Potential Deal Including Merger Of Its Consumer Healthcare Unit	29/11/18	CI
Transcript : GlaxoSmithKline Consumer Healthcare Limited, Q2 2019 Earnings Call, Nov 02, 2018	02/11/18
Glaxosmithkline Consumer Healthcare Limited Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	31/10/18	CI
Unilever, Nestle And Coca-Cola Reportedly Begin Due Diligence On Glaxosmithkline Consumer Healthcare	26/10/18	CI

Chart GlaxoSmithKline Consumer Healthcare Limited

Duration

Period

Chart GlaxoSmithKline Consumer Healthcare Limited

More charts

Company Profile

GlaxoSmithKline Consumer Healthcare Limited is an India-based healthcare company. The Company offers products such as consumer healthcare, digestive health, pain management, respiratory, oral care, and pharmaceuticals. The Company's over the counter (OTC) products include Crocin, a household medicine for relieving pain and body ache; Eno, an antacid for instant relief from acidity, gastric discomfort and heart burn; Iodex, a pain reliever available under various types, including Iodex Double Power, Iodex Headfast and Iodex Ultra Gel; Ostocalcium, a chewable calcium tablets; Otrivin, a nasal decongestant, and Sensodyne, which is a sensitivity toothpaste brand. The Company has manufacturing facilities at Nabha, Punjab; Rajahmundry, Andhra Pradesh, and Sonepat, Haryana. The Company markets its products in India, Sri Lanka, Bangladesh, Nepal, the Middle East, Myanmar, Kenya and Pakistan.

Sector

More about the company